Literature DB >> 21106329

Near-infrared fluorescence (NIRF) imaging in breast-conserving surgery: assessing intraoperative techniques in tissue-simulating breast phantoms.

R G Pleijhuis1, G C Langhout, W Helfrich, G Themelis, A Sarantopoulos, L M A Crane, N J Harlaar, J S de Jong, V Ntziachristos, G M van Dam.   

Abstract

PURPOSE: Breast-conserving surgery (BCS) results in tumour-positive surgical margins in up to 40% of the patients. Therefore, new imaging techniques are needed that support the surgeon with real-time feedback on tumour location and margin status. In this study, the potential of near-infrared fluorescence (NIRF) imaging in BCS for pre- and intraoperative tumour localization, margin status assessment and detection of residual disease was assessed in tissue-simulating breast phantoms.
METHODS: Breast-shaped phantoms were produced with optical properties that closely match those of normal breast tissue. Fluorescent tumour-like inclusions containing indocyanine green (ICG) were positioned at predefined locations in the phantoms to allow for simulation of (i) preoperative tumour localization, (ii) real-time NIRF-guided tumour resection, and (iii) intraoperative margin assessment. Optical imaging was performed using a custom-made clinical prototype NIRF intraoperative camera.
RESULTS: Tumour-like inclusions in breast phantoms could be detected up to a depth of 21 mm using a NIRF intraoperative camera system. Real-time NIRF-guided resection of tumour-like inclusions proved feasible. Moreover, intraoperative NIRF imaging reliably detected residual disease in case of inadequate resection.
CONCLUSION: We evaluated the potential of NIRF imaging applications for BCS. The clinical setting was simulated by exploiting tissue-like breast phantoms with fluorescent tumour-like agarose inclusions. From this evaluation, we conclude that intraoperative NIRF imaging is feasible and may improve BCS by providing the surgeon with imaging information on tumour location, margin status, and presence of residual disease in real-time. Clinical studies are needed to further validate these results.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 21106329     DOI: 10.1016/j.ejso.2010.10.006

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  27 in total

1.  Optimization of fluorescent imaging in the operating room through pulsed acquisition and gating to ambient background cycling.

Authors:  Kristian J Sexton; Yan Zhao; Scott C Davis; Shudong Jiang; Brian W Pogue
Journal:  Biomed Opt Express       Date:  2017-04-26       Impact factor: 3.732

2.  Multispectral visualization of surgical safety-margins using fluorescent marker seeds.

Authors:  Patrick Tk Chin; Chantal Ac Beekman; Tessa Buckle; Lee Josephson; Fijs Wb van Leeuwen
Journal:  Am J Nucl Med Mol Imaging       Date:  2012-03-28

3.  Comparison of in vivo optical systems for bioluminescence and fluorescence imaging.

Authors:  Steven K Cool; Koen Breyne; Evelyne Meyer; Stefaan C De Smedt; Niek N Sanders
Journal:  J Fluoresc       Date:  2013-04-12       Impact factor: 2.217

4.  Sentinel lymph node biopsy under fluorescent indocyanin green guidance: Initial experience.

Authors:  Fatih Aydoğan; Akif Enes Arıkan; Erman Aytaç; Mehmet Velidedeoğlu; Mehmet Halit Yılmaz; Muhammet Sait Sager; Varol Çelik; Cihan Uras
Journal:  Ulus Cerrahi Derg       Date:  2015-08-18

5.  Analysis of expression of membrane-bound tumor markers in ductal carcinoma in situ of the breast: paving the way for molecular imaging.

Authors:  Jeroen F Vermeulen; Elsken van der Wall; Arjen J Witkamp; Paul J van Diest
Journal:  Cell Oncol (Dordr)       Date:  2013-06-07       Impact factor: 6.730

Review 6.  A review of performance of near-infrared fluorescence imaging devices used in clinical studies.

Authors:  B Zhu; E M Sevick-Muraca
Journal:  Br J Radiol       Date:  2015-01       Impact factor: 3.039

7.  Advancing Molecular-Guided Surgery through probe development and testing in a moderate cost evaluation pipeline.

Authors:  Brian W Pogue; Keith D Paulsen; Sally M Hull; Kimberly S Samkoe; Jason Gunn; Jack Hoopes; David W Roberts; Theresa V Strong; Daniel Draney; Joachim Feldwisch
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2015-03-04

8.  Preclinical comparison of near-infrared-labeled cetuximab and panitumumab for optical imaging of head and neck squamous cell carcinoma.

Authors:  Kristine E Day; Larissa Sweeny; Brian Kulbersh; Kurt R Zinn; Eben L Rosenthal
Journal:  Mol Imaging Biol       Date:  2013-12       Impact factor: 3.488

9.  Early detection of heterotopic ossification using near-infrared optical imaging reveals dynamic turnover and progression of mineralization following Achilles tenotomy and burn injury.

Authors:  Joseph E Perosky; Jonathan R Peterson; Owulatobi N Eboda; Michael D Morris; Stewart C Wang; Benjamin Levi; Kenneth M Kozloff
Journal:  J Orthop Res       Date:  2014-08-02       Impact factor: 3.494

10.  Tissue-simulating phantoms for assessing potential near-infrared fluorescence imaging applications in breast cancer surgery.

Authors:  Rick Pleijhuis; Arwin Timmermans; Johannes De Jong; Esther De Boer; Vasilis Ntziachristos; Gooitzen Van Dam
Journal:  J Vis Exp       Date:  2014-09-19       Impact factor: 1.355

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.